NAMD submitted comments to CMS on the proposed rule implementing the Merit-based Incentive Payment System and Advanced Alternative Payment Model (APM) programs, which were created under the Medicare Access and CHIP Reauthorization Act of 2015. NAMD’s comments discuss the impact of the rule on state Medicaid payment and delivery system reform, and explore unique Medicaid […]
This new issue brief – developed with the support of The Commonwealth Fund – explores the importance of Medicaid state-led work in national conversations on value-based purchasing (VBP). It also explores the potential for state and federal efforts to be aligned in VBP development to achieve the maximum effect in improving health, improving care and […]
NAMD partnered with the National Association of States United for Aging and Disability (NASUAD), the National Association of State Directors of Developmental Disabilities Services (NASDDDS), and the National Association of State Mental Health Program Directors (NASMHPD) to send a joint letter to the Department of Labor (DOL). The letter outlines the state associations’ concerns with […]
NAMD submitted comments to the Health Care Payment Learning Action Network on its draft white paper on clinical episode payment for maternity care. The comments highlight state Medicaid considerations when designing a clinical episode payment model for maternity care. Read full letter.
On May 18, NAMD submitted comments to the Health Resources and Services Administration (HRSA) in response to reopened provisions of a proposed rule on the 340B drug discount program. NAMD called for HRSA to maintain its initially proposed “penny pricing” method for 340B drugs, for HRSA to align the 340B ceiling price for new drugs […]
NAMD sent a letter to sponsors of the legislation, “Advancing Care for Exceptional for Kids.” The letter addresses the bill’s underlying structure and implementation issues as well as other opportunities to enhance access to care coordination and high quality services for children with complex medical needs. Read full letter.
NAMD sent a letter to House of Representatives leadership on the need to address the privacy laws governing substance use disorder information as part of opioid legislation under consideration in the House. The letter underscores the need to amend the privacy laws of 42 CFR Part 2 to fully address the opioid crisis, and ensure […]
On April 29, NAMD sent a letter to leadership of the Senate Finance Committee and the Senate Health, Education, Labor, and Pensions Committee addressing Senators’ efforts to improve the nation’s behavioral health system. In particular, NAMD praised the Committees for their consideration of lifting restrictions on federal Medicaid payments for services provided in Institutions for […]
This memo aims to support Medicaid Directors in reviewing CMS’s final rule implementing mental health parity requirements in Medicaid under the Mental Health Parity and Addiction Equity Act of 2008. The document explores state Medicaid program and MCO roles and responsibilities under the rule, as well as the general parity requirements. It also highlights key […]
NAMD staff prepared a memo for Directors outlining key federal regulatory and legislative priorities for the remainder of the year. It provides a snapshot of major priorities for HHS, including completion of the final Medicaid managed care rule, systems work, and value-based purchasing. It also provides an assessment of legislation which is likely to impact […]